AVBP
Price
$20.06
Change
-$0.15 (-0.74%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
853.29M
Intraday BUY SELL Signals
RVMD
Price
$70.57
Change
-$0.01 (-0.01%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
13.64B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs RVMD

Header iconAVBP vs RVMD Comparison
Open Charts AVBP vs RVMDBanner chart's image
ArriVent BioPharma
Price$20.06
Change-$0.15 (-0.74%)
Volume$1.36K
Capitalization853.29M
Revolution Medicines
Price$70.57
Change-$0.01 (-0.01%)
Volume$25.96K
Capitalization13.64B
AVBP vs RVMD Comparison Chart in %
AVBP
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVBP vs. RVMD commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (AVBP: $20.18 vs. RVMD: $70.57)
Brand notoriety: AVBP and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 45% vs. RVMD: 114%
Market capitalization -- AVBP: $853.29M vs. RVMD: $13.64B
AVBP [@Biotechnology] is valued at $853.29M. RVMD’s [@Biotechnology] market capitalization is $13.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVBP and RVMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 5 TA indicator(s) are bullish while RVMD’s TA Score has 2 bullish TA indicator(s).

  • AVBP’s TA Score: 5 bullish, 4 bearish.
  • RVMD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than RVMD.

Price Growth

AVBP (@Biotechnology) experienced а +4.13% price change this week, while RVMD (@Biotechnology) price change was +10.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($13.6B) has a higher market cap than AVBP($853M). RVMD YTD gains are higher at: 61.340 vs. AVBP (-24.249). AVBP has higher annual earnings (EBITDA): -148.33M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. AVBP (236M). AVBP has less debt than RVMD: AVBP (98K) vs RVMD (133M). AVBP (0) and RVMD (0) have equivalent revenues.
AVBPRVMDAVBP / RVMD
Capitalization853M13.6B6%
EBITDA-148.33M-883.71M17%
Gain YTD-24.24961.340-40%
P/E RatioN/AN/A-
Revenue00-
Total Cash236M2.14B11%
Total Debt98K133M0%
TECHNICAL ANALYSIS
Technical Analysis
AVBPRVMD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 29 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AISHX5.83N/A
N/A
Aristotle Small/Mid Cap Equity C
ECEMX17.31N/A
N/A
Parametric Emerging Markets C
MIDHX32.24N/A
N/A
MFS International New Discovery R3
TMMAX18.37N/A
N/A
SEI Tax-Managed Mgd Volatility F (SIMT)
MBVKX21.00N/A
N/A
BlackRock Large Cap Focus Value K

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-2.46%
SYRE - AVBP
51%
Loosely correlated
-1.07%
DNLI - AVBP
51%
Loosely correlated
+0.58%
ELVN - AVBP
49%
Loosely correlated
+3.91%
RVMD - AVBP
49%
Loosely correlated
+2.07%
IDYA - AVBP
49%
Loosely correlated
+1.08%
More